Radio
Now Playing
Quickyla Radio — Click to play
Open →
Radio
Now Playing Quickyla Radio — Click to play
Open Radio →
Breaking
MINDY3: A hub between protein quality control and DNA repairIntellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026?These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside AheadThis Stock Is Up 58% This Year. Is It too Late to Buy?The wrong prescription for drug affordability

Choose Language

Select a language for news translation.

Results for "biotech" 11 articles
3 Under-the-Radar Stocks to Buy and Hold for a Decade
📈 Markets & Finance Live
3 Under-the-Radar Stocks to Buy and Hold for a Decade

Written by Prosper Junior Bakiny for The Motley Fool -> These three innovative biotechs are developing products in markets with high unmet needs. They could …

Nasdaq News 15 days ago 34
Fred Ramsdell
🔬 Science Live
Fred Ramsdell

The 2025 Nobel laureate on the need for better science communication Claudio Bresciani/TT News Agency/AFP via Getty Images Fred Ramsdell is an immunologist a…

Scientific American 15 days ago 35
Markets
S&P 5005,432.18▲ 0.42%
NASDAQ17,891.40▲ 0.87%
DOW39,118.86▼ 0.15%
BTC$67,842▲ 2.14%
ETH$3,291▲ 1.38%
GOLD$2,341/oz▼ 0.31%
OIL (WTI)$82.14▲ 0.67%
EUR/USD1.0842▼ 0.09%
GBP/USD1.2641▲ 0.22%
NIKKEI38,471▲ 1.02%
FTSE 1008,218▼ 0.28%
Full Markets →
Local Weather
—°F
Local area
58% 12 mphH:78° L:61°
Emergency Alerts
Wildfire Warning — Northern California coastal counties until 8PM
High surf advisory — Bay Area beaches through the weekend
View all alerts →
✦ AI Powered
Summarize any article instantly
Get 30-second summaries, bullet points, deep analysis, or a child-friendly version — powered by AI.
30-sec summary Bullet points Deep analysis
✦ Based on Your Interests
Trending stories you might like
Sign in to personalize
Around the World
▶ Video News
📈 Markets & Finance
3 days ago
Legend Biotech BioNTech attract buyout interest
Nasdaq News · ▶ Watch
💻 Technology
5 days ago
TechCrunch charges $190 more for Founder Summit after tonight
TechCrunch · ▶ Watch
🏥 Health
5 days ago
Moderna stock doubles in 2024, cancer vaccine trial nears August FDA decision
Nasdaq News · ▶ Watch
🔬 Science
9 days ago
MINDY3: A hub between protein quality control and DNA repair
Phys.org · ▶ Watch
📈 Markets & Finance
10 days ago
Weight loss without muscle loss? The next generation of drugs is testing the idea
Business Insider Mkt · ▶ Watch
📈 Markets & Finance
10 days ago
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026?
Nasdaq News · ▶ Watch
📈 Markets & Finance
13 days ago
These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead
Nasdaq News · ▶ Watch
📈 Markets & Finance
14 days ago
This Stock Is Up 58% This Year. Is It too Late to Buy?
Nasdaq News · ▶ Watch
🏛️ Politics
15 days ago
The wrong prescription for drug affordability
The Hill · ▶ Watch
📈 Markets & Finance
15 days ago
3 Under-the-Radar Stocks to Buy and Hold for a Decade
Nasdaq News · ▶ Watch
🔬 Science
15 days ago
Fred Ramsdell
Scientific American · ▶ Watch
Religion & Culture More →
Islam Christianity Hinduism Judaism Sikhism Interfaith Culture

More to Read

2 Biotech Stocks Worth Buying Before Their Potential Buyouts
📈 Markets & Finance
Legend Biotech BioNTech attract buyout interest
Nasdaq News · 3 days ago
Early Bird pricing ends tonight for TechCrunch Founder Summ…
💻 Technology
TechCrunch charges $190 more for Founder Summit after tonight
TechCrunch · 5 days ago
This Stock Has Already Doubled This Year and Is Still Racin…
🏥 Health
Moderna stock doubles in 2024, cancer vaccine trial nears August FDA decision
Nasdaq News · 5 days ago
MINDY3: A hub between protein quality control and DNA repair
🔬 Science
MINDY3: A hub between protein quality control and DNA repair
Phys.org · 9 days ago
Weight loss without muscle loss? The next generation of dru…
📈 Markets & Finance
Weight loss without muscle loss? The next generation of drugs is testing the id…
Business Insider Mkt · 10 days ago
Intellia Therapeutics vs. Omeros: Which Emerging Biotech St…
📈 Markets & Finance
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy …
Nasdaq News · 10 days ago
These 3 Stocks Have Crushed the Market This Year. Here's Wh…
📈 Markets & Finance
These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upsi…
Nasdaq News · 13 days ago
This Stock Is Up 58% This Year. Is It too Late to Buy?
📈 Markets & Finance
This Stock Is Up 58% This Year. Is It too Late to Buy?
Nasdaq News · 14 days ago
The wrong prescription for drug affordability
🏛️ Politics
The wrong prescription for drug affordability
The Hill · 15 days ago
3 Under-the-Radar Stocks to Buy and Hold for a Decade
📈 Markets & Finance
3 Under-the-Radar Stocks to Buy and Hold for a Decade
Nasdaq News · 15 days ago
Fred Ramsdell
🔬 Science
Fred Ramsdell
Scientific American · 15 days ago
Full view